Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues

Neurology

Volumn 44, Issue 3, 1994, Pages 474-481

  Saito, Y ^a   Sharer, L R ^b   Epstein, L G ^a   Michaels, J ^b   Mintz, M ^b   Louder, M ^a   Golding, K ^a   Cvetkovich, T A ^a   Blumberg, B M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; MESSENGER RNA; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC MARKER; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; NEUROPATHOLOGY; OPEN READING FRAME; PRIORITY JOURNAL; REGULATOR GENE;

AGED; ASTROCYTES; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; MIDDLE AGED; SPINAL CORD; TIME FACTORS;

EID: 0028230433     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.3_part_1.474     Document Type: Article

References (60)

1. Haase AT. Pathogenesis of lentiviral infections. Nature 1986;322:130-136.
2. Michaels J, Sharer LR, Epstein LG. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodefic Rev 1988;1:42-77.
3. Peluso R, Haase A, Stowring L, Edwards M, Ventura P. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 1985;147:231-236.
4. Gendelman HE, Orenstein JM, Baca LM, et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989;3:475-495.
5. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143-152.
6. Michaels J, Price RW, Rosenblum MK. Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection, and fusion. Acta Neuropathol (Berl) 1988;76:373-379.
7. Sharer LR, Cho E-S, Epstein LG. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 1985; 16:760.
8. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093.
9. Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA 1986;256:2360-2364.
10. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83:7089-7093.
11. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl) 1990; 80:92-94.
12. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121.
13. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-654.
14. Epstein LG, Sharer LR, Cho E-S, Meyenhofer MF, Navia BA, Price RW. HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res Hum Retroviruses 1984 85;l:447-454.
15. Sharer LR, Epstein LG, Cho E-S, et al. Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV- III infection of brain. Hum Pathol 1986;17:271-284.
16. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho E-S, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987;21:490-496.
17. Rhodes RH, Ward JM, Cowan RP, Moore PT. Immunohisto- chemical localization of human immunodeficiency viral antigens in formalin-fixed spinal cords with AIDS myelopathy.Clin Neuropathol 1988;8:22-27.
18. Sharer LR. Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992;51:3-11.
19. Chiodi F, Fuerstenberg A, Gidlund M, Asjo B, Fenyo EM. Infection of brain-derived cells with the human immunodeficiency virus. J Virol 1987;61:1244-1247.
20. Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger- Hodges MJ, Volsky DJ. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol 1987;61: 3774-3782.
21. Kunsch C, Wigdahl B. Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells. Virology 1989;173:715-722.
22. Tornatore CS, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 1991;65:6094-6100.
23. Kestler HW, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high viral loads and for development of AIDS. Cell 1991;65:651-662.
24. Daniel MD, Kirchoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
25. Cheng-Mayer C, Iannello P, Shaw K, Luciw PA, Levy JA. Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science 1989;246:1629-1632.
26. Cullen BR. The positive effect of the negative factor. Nature 1991;351:698-699.
27. Hovanessian AG, et al. Third forum on virology: on the HIV nef gene product. Res Virol 1992;143:31-81.
28. Blumberg BM, Epstein LG, Saito Y, Chen D, Sharer LR, Anand R. Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol 1992;66:5256-5264.
29. Lai-Goldman M, Lai E, Grody WW. Detection of HIV in formalin-fixed paraffin embedded tissues by DNA amplification. Nucleic Acids Res 1988;16:8191-8198.
30. Sharer LR, Dowling PC, Michaels J, et al. Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol 1990;16:317-331.
31. Kaminckik Y, Bashan N, Pinchasi D, et al. Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product. J Virol 1990;64:3447-3454.
32. Hammes SR, Dixon E, Malim MH, Hammes BR, Greene WC. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci USA 1989;86:9549-9553.
33. Gombert FO, Blecha W, Tahtinen M, et al. Antigenic epitopes of nef proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection. Virology 1990;176:458-466.
34. Sabatier J-M, Clerget-Raslain B, Fontan G, et al. Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients. AIDS 1989;3:215-220.
35. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J. PGP 9.5 a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983;278:224-228.
36. Wilkinson KD, Lee K, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989;241: 670-672.
37. Kent C, Clarke PJ. The immunolocalisation of the neuroendocrine specific protein PGP9.5 during neurogenesis in the rat. Brain Res Dev Brain Res 1991;58:147-150.
38. Gendelman HE, Koenig S, Aksamit A, Venkatesan S. In situ hybridization for detection of viral nucleic acid in cell cultures and tissues. In: Uhl GR, ed. In situ hybridization in brain. New York, NY: Plenum Press, 1986:203-223.
39. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994;44:481-487.
40. Parmentier HK, van Wichen DF, Gmelig Meyling FHJ, Goudsmit J, Schuurman H-J. Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue. Am J Pathol 1992;141: 1209-1216.
41. Kim S, Byrn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol 1989;63:3708-3713.
42. Pomerantz RJ, Trono D, Feinberg MB, Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 1990;61:1271-1276.
43. Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS. Structure and expression of tat, rev, and nef specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 1990;64: 3391-3398.
44. Schwartz S, Felber BK, Benko DM, Fenyo E-M, Pavlakis GN. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990;64:2519-2529.
45. Guy B, Kieny MP, Riviere Y, et al. HIV F/3'-ORF encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 1987;330:266-269.
46. Franchini G, Robert-Guroff M, Ghrayeb J, Chang NT, Wong- Staal F. Cytoplasmic localization of the HTLV-III 3'-ORF protein in cultured cells. Virology 1986;155:593-599.
47. Ovod V, Lagerstedt A, Ranki A, et al. Immunological variation and immunohistochemical localization of HIV-1 nef demonstrated with monoclonal antibodies. AIDS 1992;6:25
48. Yu G, Felsted RL. Effect of myristoylation on p27 nef subcel- lular distribution and suppression of HIV-LTR transcription. Virology 1992;187:46-55.
49. Kohleisen B, Neumann M, Herrmann R, et al. Cellular localization of Nef expressed in persistently HIV-l-infected low- producer astrocytes. AIDS 1992;6:1427-1436.
50. Brack-Werner R, Kleinschmidt A, Ludvigsen A, et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 1992;6:273-285.
51. Ranki A, Ovod V, Haltia M, Nyberg M, Aavik E, Rrohn K. High expression of nef protein associated with rapidly progressing CNS disease. Presented at the Vllth International Conference on AIDS; June 1991; Florence, Italy (abstract TuAlO).
52. Kure K, Lyman WD, Weidenheim KM, Dickson DW. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 1990;136:1085-1092.
53. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991;22:700-710.
54. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-329.
55. Epstein LG, Sharer LR, Joshi W, Fojas M, Koenigsberger MR, Oleske JM. Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol 1985;17:488-496.
56. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of HIV infection in children. Pediatrics 1986; 78:678-687.
57. Sharer LR, Cho E-S. Neuropathology of HIV infection: adults versus children. In: Rotterdam H, Meyer PR, Sommers S, Racz P, eds. Progress in AIDS pathology, vol 1. Philadelphia: Field & Woods, 1989:131-142.
58. Shaw GM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177-181.
59. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen ISY. The structure of HIV DNA in brain and blood of AIDS patients. Nature 1990;343:85-90.
60. Brinkmann R, Schwinn A, Narayan O, et al. Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol 1992;31:361-365.